J&J to Run Innovation Centers

Johnson & Johnson will establish four regional innovation centers in major life sciences communities of the world as part of a new approach to accelerate early innovation, collaboration and investment across its global healthcare businesses.

 

Targeted to open in some of the world's leading innovation hotspots in California, Boston, London and China, the Johnson & Johnson innovation centers will serve as regional hubs focused on identifying early-stage innovations, and establishing collaborations to invest in and speed development of those innovations to solve unmet needs in patients. Each innovation center will house science and technology experts and have local deal-making capabilities.

 

The innovation centers will provide scientists, entrepreneurs and emerging companies focused on early-stage opportunities with one-stop access to science and technology experts at Johnson & Johnson who can facilitate collaborations across its pharmaceutical, medical device and diagnostics and consumer companies.

 

"As a leading healthcare company in the world, our goal is to have continuous access to the best science and technology in the world," says Paul Stoffels, MD, worldwide chairman, pharmaceuticals, Johnson & Johnson (and Johnson & Johnson chief scientific officer, effective October 1). "The innovation centers allow us to be closer to where the innovation occurs, to access and invest in the best early-stage science and technology, and to fuel our business as well as the health of the innovation ecosystem overall.”

 

The four innovation centers are scheduled to be operational in the coming months.